Our findings validate thalamic CaV3.1 T-channels as a potential new target for the development or treatment of different psychiatric diseases, such as post-traumatic stress disorder, schizophrenia, anxiety, and substance abuse disorders. The gene discussed is CACNA1G; the disease is psychiatric disorder.